{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:31:06Z","timestamp":1773865866233,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We recently reported that normal aldosterone levels are associated with cardiovascular, renal, and metabolic disease in a sample of the\n              <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content>\n              general community (Visit 1). For the current analyses we used the same cohort in a new 4\u2010year follow\u2010up study (Visit 2).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              We measured aldosterone at Visit 1 and analyzed its predictive role for new diseases at Visit 2 (n=1140). We measured aldosterone at Visit 2 and investigated its associations with disease at Visit 2 (n=1368). We analyzed aldosterone continuously and we also dichotomized the variable as whether subjects were in the third tertile versus second and first tertiles. As continuous variable at Visit 1, aldosterone predicted new onset hypertension (\n              <jats:styled-content style=\"fixed-case\">HTN<\/jats:styled-content>\n              ) (\n              <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n              =1.36,\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              =1.13\u20131.63,\n              <jats:italic>P<\/jats:italic>\n              =0.001), central obesity (\n              <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n              =1.36,\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              =1.07\u20131.73,\n              <jats:italic>P<\/jats:italic>\n              =0.011), and use of lipid\u2010lowering drugs (\n              <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n              =1.25,\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              =1.05\u20131.48,\n              <jats:italic>P<\/jats:italic>\n              =0.012) at Visit 2, after adjustment for age, sex, and body mass index. When in the third tertile (8.5\u201388.6\u00a0ng\/dL), aldosterone predicted type 2 diabetes (T2\n              <jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content>\n              ,\n              <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n              =1.96,\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              =1.03\u20133.70,\n              <jats:italic>P<\/jats:italic>\n              =0.039). At Visit 2, aldosterone remained associated with\n              <jats:styled-content style=\"fixed-case\">HTN<\/jats:styled-content>\n              , obesity, and chronic kidney disease (\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              ), as reported for Visit 1. However, aldosterone was not associated with heart failure (\n              <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\n              ) at Visit 1 and 2, nor was aldosterone a predictor of\n              <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\n              between visits.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Aldosterone predicts new\n              <jats:styled-content style=\"fixed-case\">HTN<\/jats:styled-content>\n              , central obesity, T2\n              <jats:styled-content style=\"fixed-case\">DM<\/jats:styled-content>\n              , and use of lipid\u2010lowering drugs in the general community and remains associated with\n              <jats:styled-content style=\"fixed-case\">HTN<\/jats:styled-content>\n              , obesity, and\n              <jats:styled-content style=\"fixed-case\">CKD<\/jats:styled-content>\n              over 4\u00a0years. Aldosterone is not associated nor predicts\n              <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\n              . Further studies are warranted to evaluate aldosterone as therapeutic target in the general community.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.115.002505","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T03:35:13Z","timestamp":1450928113000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4\u2010Year Follow\u2010Up"],"prefix":"10.1161","volume":"4","author":[{"given":"Alessia","family":"Buglioni","sequence":"first","affiliation":[{"name":"Cardiorenal Research Laboratory College of Medicine Mayo Clinic Rochester MN"},{"name":"Division of Cardiovascular Diseases Department of Medicine College of Medicine Mayo Clinic Rochester MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Cannone","sequence":"additional","affiliation":[{"name":"Cardiorenal Research Laboratory College of Medicine Mayo Clinic Rochester MN"},{"name":"Division of Cardiovascular Diseases Department of Medicine College of Medicine Mayo Clinic Rochester MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Jeson","family":"Sangaralingham","sequence":"additional","affiliation":[{"name":"Cardiorenal Research Laboratory College of Medicine Mayo Clinic Rochester MN"},{"name":"Division of Cardiovascular Diseases Department of Medicine College of Medicine Mayo Clinic Rochester MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise M.","family":"Heublein","sequence":"additional","affiliation":[{"name":"Cardiorenal Research Laboratory College of Medicine Mayo Clinic Rochester MN"},{"name":"Division of Cardiovascular Diseases Department of Medicine College of Medicine Mayo Clinic Rochester MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research College of Medicine Mayo Clinic Rochester MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent R.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research College of Medicine Mayo Clinic Rochester MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Rodeheffer","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases Department of Medicine College of Medicine Mayo Clinic Rochester MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Sarzani","sequence":"additional","affiliation":[{"name":"Internal Medicine and Geriatrics and \u201cHypertension Excellence Centre\u201d of the European Society of Hypertension Department of Clinical and Molecular Sciences University \u201cPolitecnica delle Marche\u201d Ancon Italy"},{"name":"Italian National Research Centre on Aging \u201cU. Sestilli\u201d IRCCS\u2010INRCA Ancon Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John C.","family":"Burnett","sequence":"additional","affiliation":[{"name":"Cardiorenal Research Laboratory College of Medicine Mayo Clinic Rochester MN"},{"name":"Division of Cardiovascular Diseases Department of Medicine College of Medicine Mayo Clinic Rochester MN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.198986"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.10.7711"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080944"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.093955"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2011.232"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.190223"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033263"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010010085"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.708537"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03936"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.08.012"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.01.031"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.2.194"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-30-5-682"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)93125-K"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euje.2005.12.014"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000437738.63853.7a"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.106.25.3143"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000201443.63240.a7"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2010.04.001"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-011-0182-2"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06597.x"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f624a0"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0674"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-245415"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.197111"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2014.08.016"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2009.12.004"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009070737"},{"issue":"1","key":"e_1_3_1_31_2","first-page":"S3","article-title":"The global burden of diabetes and its complications: an emerging pandemic","volume":"17","author":"van Dieren S","year":"2010","unstructured":"van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17(suppl 1):S3\u2013S8.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3061-3"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05285"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000478"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.11.009"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2562"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04117"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000885"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.080"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.115.002505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:00:07Z","timestamp":1715594407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.115.002505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1161\/JAHA.115.002505"],"URL":"https:\/\/doi.org\/10.1161\/jaha.115.002505","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"2015-09-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e002505"}}